The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats

Endocrinology

Volumn 139, Issue 3, 1998, Pages 1411-1419

  Yamamoto, Michiko ^a,b   Fisher, John E ^a   Gentile, Michael ^a   Seedor, J Gregory ^a   Leu, Chih Tai ^a   Rodan, Sevgi B ^a   Rodan, Gideon A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ECHISTATIN; INTEGRIN;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLOOD LEVEL; BONE ATROPHY; BONE METABOLISM; BONE TURNOVER; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031737963     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.3.5831     Document Type: Article

References (49)

1. Riggs BL 1991 Overview of osteoporosis. West J Med 154:63-77
2. Kalu DN 1991 The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175-192
3. Frost HM, Jee WSS 1992 On the rat model of human osteopenias and osteoporosis. Bone Miner 18:227-236
4. Holtrop ME, King GJ 1977 The ultrastructure of the osteoclast and its functional implications. Clin Orthop 123:177-196
5. Baron R, Neff L, Brown W, Courtoy PJ, Louvard D, Farquhar MG 1988 Polarized secretion of lysosomal enzymes: co-distribution of cation independent mannose-6-phosphate receptors and lysosomal enzymes along the osteoclast exocytic pathway. J Cell Biol 106:1863-1872
6. Horton MA, Davies J 1989 Perspectives: adhesion receptors in bone. J Bone Miner Res 4:803-807
7. Horton MA, Rodan GA 1996 Integrins as therapeutic targets in bone disease. In: Horton MA (ed) Adhesion Receptors as Therapeutic Targets in Bone Disease. CRC Press, Boca Raton, pp 223-245
8. Hynes RO 1992 Integrins: versatility, modulation, and signalling in cell adhesion. Cell 69:11-25
9. Ruoslahti E, Pierschbacher M 1986 Arg-Gly-Asp: a versatile cell recognition sequence. Cell 44:517-518
10. Pierschbacher MD, Ruoslahti E 1984 Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309:30-33
11. Gould RJ, Polokoff MA, Friedman PA, Huang T-F, Holt JC, Cook JJ, Niewiarowski S 1990 Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med 195:168-171
12. Gan Z-R, Gould RJ, Jacobs JW, Friedman PA, Polokoff MA 1988 Echistatin: a potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus. J Biol Chem 263:19827-19832
13. Clover J, Dodds RA, Gowen M 1992 Integrin subunit expression by human osteoblasts and osteoclasts in situ and in culture. J Cell Sci 103:267-271
14. 1 integrins. J Biol Chem 268:16737-16745
15. 3 integrin subunits in rat osteoclasts in situ. J Bone Miner Res 8:403-414
16. Hughes DE, Salter DM, Dedhar S, Simpson R 1993 Integrin expression in human bone. J Bone Miner Res 8:527-533
17. Sato M, Sardana MK, Grasser WA, Garsky VM, Murray JM, Gould RJ 1990 Echistatin is a potent inhibitor of bone resorption in culture. J Cell Biol 111:1713-1723
18. Horton MA, Dorey EL, Nesbitt SA, Samanen J, Ali FE, Stadel JM, Nichols A, Greig R, Helfrich MH 1993 Modulation of vitronectin receptor-mediated osteoclast adhesion by arg-gly-asp peptide analogs: a structure-function analysis. J Bone Miner Res 6:239-247
19. Fisher JE, Caulfield MP, Sato M, Quartuccio HA, Gould RJ, Garsky VM, Rodan GA, Rosenblatt M 1993 Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glysyl-aspartyl"(RGD)-containing protein. Endocrinology 132:1411-1413
20. Crippes BA, Engleman VW, Settle SL, Delarco J, Ornberg RL, Helfrich MH, Horton MA, Nickols GA 1996 Antibody to β3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat. Endocrinology 137:918-924
21. 3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J Clin Invest 99:2284-2292
22. Chambers TJ, Fuller K, Darby JA, Pringle JAS, Horton MA 1986 Monoclonal antibodies against osteoclasts inhibit bone resorption in vitro. Bone Miner 1:127-135
23. Davies J, Warwick J, Totty N, Philp R, Helfrich M, Horton M 1989 The osteoclast functional antigen implicated in the regulation of bone resorption is biochemically related to vitronectin receptor. J Cell Biol 109:1817-1826
24. Horton MA, Taylor ML, Arnett TR, Helfrich MH 1991 Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp Cell Res 195:368-375
25. Lakkakorpi PT, Horton MA, Helfrich MH, Karhukorpi EK, Väänänen HK 1991 Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J Cell Biol 115:1179-1186
26. Garsky VM, Lumma PK, Freidinger RM, Pitzenberger SM, Randall WC, Veber DF, Gould RJ, Friedman PA 1989 Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogs. Proc Natl Acad Sci USA 86:4022-4026
27. Jacobson MA, Forma FM, Buenaga RF, Hofmann KJ, Schultz LD, Gould RJ, Friedman PA 1989 Expression and secretion of biologically active echistatin in Saccharomyces cerevistae. Gene 85:511-516
28. Pytela R, Pierschbacher MD, Argraves S, Suzuki S, Ruoslahti E 1987 Arg-Gly-Asp adhesion receptors. Methods Enzymol 144:475-489
29. Yamamoto M, Balena R, Markatos A, Gentile M, Garsky VM, Rodan GA, Direct demonstration of inhibitory effect of echistatin on PTH-induced bone resorption. in vivo in mice. Program of the Annual Meeting of the American Society for Bone and Mineral Research, Tampa, FL, 1993, p S123 (Abstract)
30. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
31. Horton MA, Lewis D, McNulty K, Pringle JAS, Chambers TJ 1985 Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific antigens. Cancer Res 5:5663-5669
32. King KL, D'Anza JJ, Bodary S, Pitti R, Siegel M, Lazarus RA, Dennis MS, Hammonds Jr RG, Kukreja SC 1994 Effects of kistrin on bone resorption in vitro and serum calcium in vivo. J Bone Miner Res 9:381-387
33. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F 1994 Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:1189-1196
34. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF 1996 Estrogen promotes apoptosis of murine osteoclasts mediated by TGFβ. Nature Med 2:1132-1136
35. Beamer WG, Donahne LR, Rosen CJ, Baylink DJ 1996 Genetic variability in adult bone density among inbred strains of mice. Bone 18:397-403
36. Bain SD, Bailey MC, Celino DL, Lantry MM, Edwards MW 1993 High dose estrogen inhibits bone resorption and stimulates bone formation in the ovariectomized mouse. J Bone Miner Res 8:435-442
37. Wronski TJ, Cintron M, Doherty AL, Dann LM 1988 Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123:681-686
38. Balena R, Toolan BC, Shea M, Markatos A, Myers ER, Lee SC, Opas EE, Seedor JG, Klein H, Frankenfield D, Quartuccio H, Fioravanti C, Clair J, Brown E, Hayes WC, Rodan GA 1993 The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest 92:2577-2586
39. Masarachia P, Yamamoto M, Leu C-T, Rodan G, Duong L 1998 Histomorphometric evidence for echistatin inhibition of bone resorption in mice with secondary hyperparathyroidism. Endocrinology 139:1401-1410
40. 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 121:163-170
41. 3 antagonists promote rumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1164
42. 1 Integrins and osteoclast function: involvement in collagen recognition and bone resorption. Bone 19:317-328
43. 7 high affinity echistatin binding sites (RGD-integrins). Program of the Annual Meeting of the American Society for Bone and Mineral Research, Cincinnatti, OH, 1997, p S416 (Abstract)
44. 5 in a reciprocal manner during osteoclastogenesis. Program of the Annual Meeting of the American Society for Bone and Mineral Research, Baltimore, MD, 1995, p S163 (Abstract)
45. 1-mediated cell migration toward fibronectin. J Biol Chem 272:29380-29389
46. Kanehisa J, Heersche JNM 1988 Osteoclastic bone resorption: in vitro analysis of the rate of resorption and migration of individual osteoclasts. Bone 9:73-90
47. 3, in osteoclasts. A study using confocal laser scanning microscopy. J Cell Sci 104:663-670
48. 3 ligand inhibits osteoclast activity in vitro and in vivo. Program of the Annual Meeting of the American Society for Bone and Mineral Research, Seattle, WA, 1996, p S289 (Abstract)
49. 3 vitronectin receptor. Program of the Annual Meeting of the American Society for Bone and Mineral Research, Seattle, WA, 1996, p S228 (Abstract)